Improved quality control of [177Lu]Lu-PSMA I&T

被引：0
|
作者：
Martin Kraihammer
Piotr Garnuszek
Andreas Bauman
Michael Maurin
Manuel Alejandre Lafont
Roland Haubner
Elisabeth von Guggenberg
Michael Gabriel
Clemens Decristoforo
机构：
[1] Medical University Innsbruck,Department of Nuclear Medicine
[2] Kepler University Hospital,Department of Nuclear Medicine and Endocrinology
[3] National Centre for Nuclear Research,Radioisotope Centre POLATOM
[4] University Hospital Basel,Division of Radiopharmaceutical Chemistry
来源：
EJNMMI Radiopharmacy and Chemistry | / 8卷
关键词：
PSMA; [; Lu]Lu-PSMA I&T; Zadavotide guraxetan; Radionuclide therapy; Quality control; HPLC; TLC; Validation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Correction to: Dual Radionuclide Therapy: The Synergistic Effects of [161Tb]Tb-PSMA and [177Lu]Lu-PSMA in Advanced Prostate Cancer Post [177Lu]Lu-PSMA Failure (vol 58, pg 381, 2024)
    Abdlkadir, Ahmed Saad
    Abufara, Alaa
    Al-Ibraheem, Akram
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, 59 (01) : 94 - 94
  • [32] Cancer-control outcomes with [177Lu]Lu-PSMA Radioligand Therapy in elderly, frail or comorbid mCRPC patients
    Wenzel, Mike
    Siech, Carolin
    Garcia, Cristina Cano
    Humke, Clara
    Groener, Daniel
    Kriegmair, Maximilian
    Graefen, Markus
    Maurer, Tobias
    Salomon, Georg
    Banek, Severine
    Chun, Felix K. H.
    Mandel, Philipp
    THERANOSTICS, 2025, 15 (07): : 2672 - 2679
  • [33] Kidney absorbed radiation doses for [177Lu]Lu-PSMA-617 and [177Lu]Lu-PSMA-I&T determined by 3D clinical dosimetry
    Uijen, Maike J. M.
    Prive, Bastiaan M.
    van Herpen, Carla M. L.
    Westdorp, Harm
    van Gemert, Willemijn A.
    de Bakker, Maarten
    Gotthardt, Martin
    Konijnenberg, Mark W.
    Peters, Steffie M. B.
    Nagarajah, James
    NUCLEAR MEDICINE COMMUNICATIONS, 2023, 44 (04) : 270 - 275
  • [34] Experience of rescue therapy with [177Lu]Lu-rhPSMA-10.1 in patients with primary or acquired resistance to [177Lu]Lu-PSMA-I&T
    Gaeble, Alexander
    Dierks, Alexander
    Rinscheid, Andreas
    Patt, Marianne
    Wienand, Georgine
    Pfob, Christian H.
    Kircher, Malte
    Fukushima, Kazuhito
    Nikolic, Ana Antic
    Enke, Johanna S.
    Janzen, Tilman
    Steinestel, Julie
    Kempter, Hildegard
    Trepel, Martin
    Weckermann, Dorothea
    Lapa, Constantin
    Bundschuh, Ralph A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, 52 (03) : 970 - 978
  • [35] Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [177Lu]Lu-PSMA I&T during long-term follow-up
    Philipp E. Hartrampf
    Anna Katharina Seitz
    Franz-Xaver Weinzierl
    Sebastian E. Serfling
    Andreas Schirbel
    Steven P. Rowe
    Hubert Kübler
    Andreas K. Buck
    Rudolf A. Werner
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 4262 - 4270
  • [36] Quality Control of Therapeutic Radiopharmaceuticals: A Radio-TLC and HPLC analysis comparison, exemplified by clinical implementation of [177Lu]Lu-PSMA
    Hooijman, E.
    Ntihabose, C. M.
    Reuvers, T. G. A.
    Aalbersberg, E. A.
    Koolen, S. L. W.
    Hendrikx, J. J. M.
    de Blois, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S662 - S662
  • [37] Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [177Lu]Lu-PSMA I&T during long-term follow-up
    Hartrampf, Philipp E.
    Seitz, Anna Katharina
    Weinzierl, Franz-Xaver
    Serfling, Sebastian E.
    Schirbel, Andreas
    Rowe, Steven P.
    Kuebler, Hubert
    Buck, Andreas K.
    Werner, Rudolf A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (12) : 4262 - 4270
  • [38] Radioactivity levels in the saliva of patients undergoing targeted radioligand therapy with [177Lu]Lu-PSMA-I&T and [177Lu]Lu-DOTA-TOC
    Christian Schedeit
    Nasir Gözlügöl
    Radi Saiyed Alsheikh
    Mohamed Shelan
    Robert Seifert
    Federico Caobelli
    Urs Borner
    Tateyuki Iizuka
    Benoît Schaller
    Axel Rominger
    Paul Cumming
    Ali Afshar-Oromieh
    Konstantinos G. Zeimpekis
    Clinical Oral Investigations, 29 (5)
  • [39] The value of tumor markers in men with metastatic prostate cancer undergoing [177Lu]Lu-PSMA therapy
    Yordanova, Anna
    Linden, Paula
    Hauser, Stefan
    Feldmann, Georg
    Brossart, Peter
    Fimmers, Rolf
    Essler, Markus
    Holdenrieder, Stefan
    Ahmadzadehfar, Hojjat
    PROSTATE, 2020, 80 (01): : 17 - 27
  • [40] Clinical dosimetry in [177Lu]Lu-PSMA therapy: fewer imaging time points, still useful
    De Vries-Huizing, D.
    Rijkhorst, E.
    Owers, E.
    De Wit-Van der Veen, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S126 - S126
12345